Increasing prevalence of glaucoma, growing aging population with presbyopia (long-sightedness) and growing demand for more efficient and innovative glaucoma management technologies that provide real-time and non-invasive diagnosis of sugar levels in diabetic patients are driving the market growth. Additionally, rise in cases of diabetes-related complications such as cataracts, eye disorders, and blindness is contributing to …